Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-24

FDA Approved: LANTHANUM CARBONATE — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved Cipla USA Inc.'s generic lanthanum carbonate (original application) for the treatment of hyperphosphatemia in adults with chronic kidney disease on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LANTHANUM CARBONATE (lanthanum carbonate)

Snippet

ORIG AP for LANTHANUM CARBONATE (LANTHANUM CARBONATE)